A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients

Overview of attention for article published in SpringerPlus, December 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,051 followers.

A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer… https://t.co/HJTE5uX6jV #breastcancer

Reply Repost Favourite